| LDR | | 00000cam u2200205 a 4500 |
| 001 | | 000000888531 |
| 005 | | 20140219161741 |
| 008 | | 130211s2013 enk b 001 0 eng d |
| 010 | |
▼a 2013932949 |
| 015 | |
▼a GBB359380
▼2 bnb |
| 020 | |
▼a 9780857932457 (hardback):
▼c GBP90 |
| 020 | |
▼a 0857932454 (hardback) |
| 020 | |
▼z 9780857932464 (e-book) |
| 020 | |
▼z 0857932462 (e-book) |
| 035 | |
▼a (OCoLC)ocn852806743 |
| 040 | |
▼a Uk
▼b eng
▼c Uk
▼d OCLCO
▼d DGW-L
▼d YDXCP
▼d 225009
▼d AzU
▼d DLC
▼e rda |
| 042 | |
▼a lccopycat |
| 050 | 00 |
▼a K1519.D78
▼b P53 2013 |
| 082 | 04 |
▼a 346.0486
▼2 23 |
| 090 | |
▼a 346.0486
▼b 013e |
| 245 | 00 |
▼a Pharmaceutical innovation, competition and patent law:
▼b a trilateral perspective/
▼c edited by Josef Drexl, Director, Max Planck Institute for Intellectual Property and Competition Law, Munich, Germanyl; Nari Lee, Professor of Intellectual Property Law, Department of Accounting and Commercial Law, Hanken School of Economics, Helsinki. |
| 260 | |
▼a Cheltenham, UK ;
▼a Northampton, MA, USA:
▼b Edward Elgar,
▼c 2013. |
| 300 | |
▼a viii, 337 p.;
▼c 25 cm. |
| 504 | |
▼a Includes bibliographical references and index. |
| 505 | 00 |
▼t The patentability of genetic diagnostics in US law and policy /
▼r Rochelle C. Dreyfuss --
▼t Patentability of pharmaceutical innovations : the European perspective /
▼r Rainer Moufang --
▼t Patentability of medical methods in Japan /
▼r Nari Lee --
▼t Patent term restoration and non-patent exclusivity in the US /
▼r Margo A. Bagley --
▼t Clinical data, data exclusivity and private investment protection in Europe /
▼r Christian R. Fackelmann --
▼t Patent term extension in Japan : an academic and comparative perspective /
▼r Ryoko Iseki --
▼t Recent UK case law on supplementary protection certificates /
▼r Richard Arnold --
▼t Patent term extension in Japan : focusing on the Pacif Capsule decision /
▼r Toshiaki Imura --
▼t Strategic patenting by the pharmaceutical industry : towards a concept of abusive practices of protection /
▼r Hanns Ullrich --
▼t Anticompetitive marketing in the context of pharmaceutical switching in Europe /
▼r Bengt Domeij --
▼t AstraZeneca and the EU sector inquiry : when do patent filings violate competition law? /
▼r Josef Drexl. |
| 650 | 0 |
▼a Drugs
▼z United States
▼x Patents. |
| 650 | 0 |
▼a Drugs
▼z European Union countries
▼x Patents. |
| 650 | 0 |
▼a Drugs
▼z Japan
▼x Patents. |
| 650 | 0 |
▼a Pharmaceutical industry
▼x Technological innovations. |
| 650 | 0 |
▼a Antitrust law
▼z European Union countries. |
| 700 | 1 |
▼a Drexl, Josef,
▼e editor of compilation. |
| 700 | 1 |
▼a Lee, Nari,
▼e editor of compilation. |
| 990 | |
▼a 문경록
▼b 문경록 |